Glaxosmithkline Share Price | |
---|---|
Price | 1,636.00 |
Bid | 1,538.00 |
Ask | 1,700.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 1,636.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 4.09b |
Market Capitalisation | £66.85b |
Market Size | 1,500 |
52 Week High | 1,719.80 |
52 Week High Date | 07-Mar-2024 |
52 Week Low | 1,302.60 |
52 Week Low Date | 11-Jul-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 13.45395 |
Earnings | 121.60 |
Dividend | 55.50 |
Yield | 3.392% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-Apr-24 | 18:45:01 | 1,654.132 | 50,047 | Unknown* | 1,638.00 | 1,639.00 | 827.84k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:09:57 | 1,651.021 | 51,058 | Unknown* | 1,638.00 | 1,639.00 | 842.98k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:09:35 | 1,636.834 | 1,894 | Unknown* | 1,638.00 | 1,639.00 | 31.00k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:08:48 | 1,641.10336 | 717 | Unknown* | 1,638.00 | 1,639.00 | 11.77k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:08:26 | 1,638.382 | 35,824 | Unknown* | 1,638.00 | 1,639.00 | 586.93k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:07:40 | 1,650.678 | 60,750 | Unknown* | 1,638.00 | 1,639.00 | 1m | O Ordinary Was reported as OTC |
24-Apr-24 | 17:56:07 | 1,635.836 | 16,419 | Unknown* | 1,638.00 | 1,639.00 | 268.59k | O Ordinary Was reported as OTC |
24-Apr-24 | 17:54:39 | 1,655.469 | 630 | Unknown* | 1,638.00 | 1,639.00 | 10.43k | O Ordinary Was reported as OTC |
24-Apr-24 | 17:54:39 | 1,636.00 | 131 | Unknown* | 1,638.00 | 1,639.00 | 2,143 | O Ordinary Was reported as OTC |
24-Apr-24 | 17:54:39 | 1,636.00 | 1,887 | Unknown* | 1,638.00 | 1,639.00 | 30.87k | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
19-Apr-24 | 16-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 39.79 | USD | 2,906,213 | 3,370,704 |
19-Apr-24 | 16-Apr-24 | Buy Dividends | Emma Walmsley held the position of CEO at the time of this trade.Emma Walmsley | 1,611.28 | GBX | 1,840,922 | 2,190,842 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Anne Beal held the position of Independent Non-Executive Director at the time of this trade.Anne Beal | 40.96 | USD | 9 | 3,375 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Harry (Hal) C. Dietz held the position of Independent Non-Executive Director at the time of this trade.Harry (Hal) C. Dietz | 40.96 | USD | 9 | 3,118 |
15-Apr-24 | 12-Apr-24 | Buy Dividends | Hal Barron held the position of Non-Executive Director at the time of this trade.Hal Barron | 40.96 | USD | 13 | 464,491 |
At GSK, we unite science, technology and talent to get ahead of disease together